A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

Overview

The purpose of this clinical research study is to determine if different dosage regimens of Sinemet® CR (Carbidopa/levodopa) are dose proportional

Full Title of Study: “An Open Label, Multiple-Dose Study ot Determine the Plasma Levodopa Profiles of Sinemet® CR (Carbidopa/Levodopa) at 4 Daily Dose Levels in Healthy Subjects”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective

Interventions

  • Drug: Sinemet® controlled release (Carbidopa/levodopa)

Participating in This Clinical Trial

  • Key inclusion and exclusion criteria for healthy volunteers will be used – Males and females aged 50-75
  • Gender Eligibility: All

    Minimum Age: 50 Years

    Maximum Age: 75 Years

    Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

    Investigator Details

    • Lead Sponsor
      • Bristol-Myers Squibb
    • Overall Official(s)
      • Bristol-Myers Squibb, Study Director, Bristol-Myers Squibb

    Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

    At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.